Inicio>>Signaling Pathways>> Immunology/Inflammation>> PGE synthase>>mPGES1-IN-3

mPGES1-IN-3

Catalog No.GC36649

mPGES1-IN-3 (Compuesto 17d) es un inhibidor microsomal potente y selectivo de la prostaglandina E2 sintasa-1 (mPGES-1), que muestra una excelente enzima mPGES-1 (IC50: 8 nM), células (A549 IC50: 16,24 nM) y potencia de la sangre entera humana (IC50: 249,9 nM).

Products are for research use only. Not for human use. We do not sell to patients.

mPGES1-IN-3 Chemical Structure

Cas No.: 1469976-70-2

Tamaño Precio Disponibilidad Cantidad
100mg Please Inquire Please Inquire
250mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

mPGES1-IN-3 (Compound 17d) is a potent and selective microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor, which exhibits excellent mPGES-1 enzyme (IC50: 8 nM), cell (A549 IC50: 16.24 nM) and human whole blood potency (IC50: 249.9 nM)[1]. IC50: 8 nM (mPGES-1)[1]

[1]. Muthukaman N, et al. Discovery of 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino[2',3':3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor. Bioorg Med Chem Lett. 2016 Dec 15;26(24):5977-5984.

Reseñas

Review for mPGES1-IN-3

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for mPGES1-IN-3

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.